On the first day of the 2016 CardioStim sessions, I am happy to report a "positive" study on percutaneous left atrial appendage closure [1]. Notice I did not write Watchman. In Europe, the majority of ...

The 45-day post-implantation results support use of a next-generation device in people with atrial fibrillation, but caution is advised until longer-term results are available.

Please provide your email address to receive an email when new articles are posted on . “Surgical left atrial appendage occlusion reduced ischemic stroke by 33%. After the first high-risk ...

Kadlec Regional Medical Center is now providing the WATCHMAN device, a heart implant designed to prevent strokes in people with atrial fibrillation (AFib) not linked to heart ...

Left atrial appendage occlusion might be a treatment option for patients on dialysis with atrial fibrillation. Left atrial appendage occlusion (LAAO) placement is associated with a reduced risk for ...

Patients who had leakage to the left atrial appendage due to incomplete device sealing after left atrial appendage occlusion (LAAO) experienced more clotting and bleeding events within a year ...

A decision model found that the relative clinical benefit of left atrial appendage occlusion (LAAO) and oral anticoagulants (OAC) in patients with atrial fibrillation depends on the patients' baseline ...

No benefit in terms of prevention of ischemic stroke, transient ischemic attack and cardiovascular mortality after 1 year was observed when surgical left atrial appendage occlusion was performed in ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Atrial fibrillation (AF) is the irregular and rapid beating of the atria. Patients with AF may be asymptomatic or may have symptoms such as fatigue, palpitations, chest pain, shortness of breath and ...